Ticker ADIL – Adial Pharma – sales, description, marketcap – Tickerday.com

ADIL

Adial Pharma

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 41.09M; Volume: 93.92M; AvgVol 3m: 2.53M; Beta: –;

Cost estimate:

P/E: –; EPS: -0.79; EPS growth quarter/prev quarter: 23.20%;

EPS growth this year: 64.30%; EPS growth past 5 years: ;

EPS ttm: -0.74;

P/S: ; P/B: 2.76; P/Cashflow: 3.30; P/FCF: ;

Sales: –; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -96.50%; ROE – return on equity: -104.10%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 31.74%; Insider Transactions:-7.71%;

Institutional Ownership: 11.30%; Institutional Transactions: 150.72%;

Data update: 07.10.2020.